Lluís masana
@lluismasana
Metge. Internista. Lipidòleg
The exposome offers a vital lens for future research, policy, and preventive cardiovascular medicine, helping to address the health burden posed by our changing environment 🔗 atherosclerosis-journal.com/article/S0021-… @society_eas #EASSoMe
A groundbreaking study just published in @Nature reveals a gut microbiota-derived metabolite as both a biomarker and driver of early atherosclerosis. #CardioTwitter #MedTwitter 👇 👇 1/ 💡 Imidazole Propionate (ImP)—a microbial metabolite previously linked to T2D—is now shown to…
N Engl J Med . 2025 Jul 24;393(4):405-407. doi: 10.1056/NEJMclde2414458 A Catalunya no ens ho plantajem perque les guies de l’ICS consideren mala pràctica clínica determimar el colesterol abans dels 18anys. I tant panxos !!! Ni detecció de risc , ni detecció de HF. Actuem!

Nearly half of dementia cases could be prevented or delayed by tackling 14 risk factors starting in childhood, including two new risks—high cholesterol and vision loss, suggests report from the Lancet Commission on dementia. On #WorldBrainDay, explore the report ➡️…
👉Managing Dyslipidemia in 2025: The Era of Precision Lipidology ☝️As we move through 2025, dyslipidemia management has clearly evolved beyond the traditional statin + ezetimibe approach. ☝️We now have an expanding armamentarium of targeted therapies addressing…
📊 Not all apoB particles are created equal! New @EuroHeartJ study shows CAD risk rises with apoB count, but particle type & size matter too 🧬 A more nuanced view of atherogenic lipoproteins could refine risk stratification. 🔗 doi.org/10.1093/eurhea… #CardioTwitter…
☝️No estimate of the apoB lipoprotein-related risk of CVD is complete without measurement of both apoB and Lp(a) ApoB is the true core marker of atherogenic particle burden, and Lp(a) is an independent, non-negotiable player in cardiovascular risk. ✅ ApoB reflects the number…
Risk factors are rising, even as care improves. This global forecast reveals a syndemic of #CVD risk fueled by aging and growth 📊⚠️ 🔗 jacc.org/doi/10.1016/j.… #JACC #GBDstudy
🧬 ¿Envejecemos igual en todo el mundo? Un estudio en 161.981 personas de 40 países revela que el envejecimiento acelerado depende del exposoma 🌍: aire, desigualdad, migración, política, ingresos... 🌱 Europa envejece mejor; África, más rápido. nature.com/articles/s4159…
La salut planetaria influeix en la salut humana. Publicat al Lancet En el proper congres de la SOC XULA. a Reus en parlarem. Vine !!!

Adherence to the The Planetary Health Diet Index is associated with a ⬇️ risk of #CVD. This study provides empirical evidence that this dietary pattern benefits cardiovascular health 🫀 academic.oup.com/eurjpc/article… @escardio @AboyansV @SilCastelletti @PeroneFrancesco @andreagallardo
Multiomics in atherosclerotic cardiovascular disease - Atherosclerosis atherosclerosis-journal.com/article/S0021-… The future is now. Beautifull review from AtheroNet group. Proud of taking part of this action!

Widespread lipoprotein alterations in a REDUCE-IT like population: The icosapent ethyl (IPE)-NMR avatar study - Nutrition, Metabolism and Cardiovascular Diseases nmcd-journal.com/article/S0939-… Patiens similar to those included in the REDUCE-IT have full lipoprotein alterations beyond TG
2n #CongrésXULA ➡️ “El teu Congrés de Prevenció Cardiovascular” 📄 Presenta la teva comunicació o cas clínic abans del 8/9/25! 📧 Enviaments: [email protected] 📍Bases i info: soc-xula.org/congrés-xula-2…
Tenir HTA>130 mmHg + C-noHDL > 130 mg/dl + IMC (<20 o >25) + diabetis + tabaquisme roba 14.5 anys de vida a les dones i 11.8 als homes. Dades de GBD. Vosaltres mateixos !! NEJM March 30, 2025. Vol 393. Veniu al Congres de la SOC XULA i ho parlem. 2-4 Octubre (Reus)
A la darrera sessió de #CohesióXULA hem parlat de la dificultat a Catalunya d’assolir els objectius en #cLDL amb els criteris de finançament dels nous farmacs hipolipemiants? Teniu la gravació disponible a: 🌐 soc-xula.org/cohesio-xula 📺 YouTube youtu.be/UQ_GqjpvQZ0 #sócxula
🗓️ El 26 de juny, t’esperem a la 6a sessió Cohesió XULA’25 amb el Dr. Joan Pedro-Botet de l’@hospitaldelmar 🔬 Com assolir els objectius de #cLDL amb els criteris de finançament dels nous fàrmacs hipolipemiants? 🕗8:15h – 8:45h 📡 Connecta’t en directe: lc.cx/MCF3Fs
DESENTRAÑANDO LA RESISTENCIA A LA INSULINA MUSCULAR: MECANISMOS MOLECULARES Y PAPEL RESTAURATIVO DEL EJERCICIO FÍSICO ¡¡¡A leer, zagales!!! ahajournals.org/doi/10.1161/CI…
THE EVOLVING FIELD OF OBESITY MANAGEMENT 📌From diabetes management to cardiovascular protection 📌From Liraglutide to Amycretin, including nutrient receptor agonists K757, K833 📌From Obesity indication to kidney-liver-peripheral artery disease treament... and more yet to come
🔴¿Sabías que el aceite de oliva virgen extra contiene polifenoles y ácido oleico, aliados de tu salud cardiovascular? Ambos compuestos tienen efectos antiinflamatorios, antioxidantes y protectores frente a la hipertensión, el colesterol elevado y la arteriosclerosis. ☀️Incluir…